TOP1 and breast cancer: In two other studies, jorunnamycin A and talaroconvolutin-A were found to suppress MIBC via targeting fatty acid synthase (FASN) and topoisomerase 1 (TOP1), and cell cycle and ferroptosis, respectively, which could be a potential candidate for treating BC (122, 123).